Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery
Conditions: Stage I Uterine Sarcoma; Uterine LeiomyosarcomaInterventions: Drug: doxorubicin hydrochloride; Drug: gemcitabine hydrochloride; Drug: docetaxel; Biological: filgrastim; Biological: pegfilgrastim; Other: clinical observationSponsors: Gynecologic Oncology Group; National Cancer Institute (NCI)Recruiting - verified February 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Docetaxel | Filgrastim | Leiomyosarcoma | Neulasta | Neupogen | Research | Sarcomas | Taxotere | Uterine Sarcoma